Ozempic Heartburn: How Common, How Long It Lasts, What Helps
The Ozempic label names dyspepsia as a reported side effect but gives no trial rate for it.
- In the label
- Listed, no rate given
- Label term
- dyspepsia
Ozempic overview
Its half-life is about 1 week. At 7 d, half of it is gone; after five half-lives (35 d), about 3% remains.
In SUSTAIN 1, people with type 2 diabetes lost 4.7 kg over 30 weeks, compared with 1.2 kg on placebo.
In US dollars, monthly figures cover list prices and self-pay offers. The maker's price page provides each figure.
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.
What the Ozempic label lists instead
The Ozempic label gives no rate for heartburn or indigestion. These five side effects are the ones it lists most often, and each one comes with a rate.
| Side effect | Placebo | Ozempic 0.5 mg | Ozempic 1 mg | More than placebo, 1 mg |
|---|---|---|---|---|
| Nausea | 6.1% | 15.8% | 20.3% | +14.2 points |
| Vomiting | 2.3% | 5% | 9.2% | +6.9 points |
| Diarrhea | 1.9% | 8.5% | 8.8% | +6.9 points |
| Abdominal pain | 4.6% | 7.3% | 5.7% | +1.1 points |
| Constipation | 1.5% | 5% | 3.1% | +1.6 points |
Reference: Ozempic label (DailyMed).
Heartburn: a comparison of Ozempic and other GLP-1s
Each label describes its own trials, which included different groups of people. Use the information as a rough guide.
Pill forms are covered in the table too, including Foundayo.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
 Foundayo | 16% | 9 mg | 4% | Adults with obesity or overweight (weight management) |
 Zepbound | 10% | 15 mg | 4% | Adults with obesity or overweight (weight management) |
 Saxenda | 9.6% | all doses | 2.7% | Adults with obesity or overweight (weight management) |
 Wegovy | 9% | 2.4 mg | 3% | Adults with obesity or overweight (weight management) |
 Mounjaro | 8% | 5 mg | 3% | Adults with type 2 diabetes |
 Victoza | 7% | 1.8 mg | 1% | Adults with type 2 diabetes |
| Byetta | 6% | all doses | 3% | Adults with type 2 diabetes |
 Trulicity | 5.8% | 1.5 mg | 2.3% | Adults with type 2 diabetes |
| Ozempic | Listed, no rate given | – | – | – |
 Rybelsus | Listed, no rate given | – | – | – |
References: Wegovy label (DailyMed), Mounjaro label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).
Source: FDA label (DailyMed).
What may explain it?
These medicines slow the rate at which your stomach empties. Food stays in your stomach longer, which can cause heartburn and indigestion. This most often happens after a large or fatty meal.
Information from health.clevelandclinic.org.
Details mentioned in the Ozempic label
Here, the label lists heartburn and indigestion exactly:
“associated with OZEMPIC (frequencies listed, respectively, as: placebo; 0.5 mg; 1 mg): dyspepsia (1.9%, 3.5%, 2.7%), eructation (0%, 2.7%, 1.1%), flatulence (0.8%, 0.4%, 1.5%), gastroesophageal”
Source: FDA label (DailyMed).
What helps, step by step
- For now, stay away from spicy and fatty foods.
- After you eat, remain upright instead of lying down.
- Choose smaller meals, and stop once you feel full. These medicines slow down how fast your stomach empties.
- Eat slowly. Your brain needs some time to sense that you are full.
- Sugary foods and fatty or greasy foods often bring on symptoms, so limit both.
- Let your prescriber know if it does not ease. Another GLP-1 may be suggested, or the dose increases may be slowed.
Before taking any drugstore product, check it with the GLP-1 interactions checker.
Information from health.clevelandclinic.org.